{"id":3296,"date":"2026-06-07T18:02:06","date_gmt":"2026-06-07T16:02:06","guid":{"rendered":"https:\/\/arevipharma.com\/pharmaceutical-active-ingredients\/"},"modified":"2026-08-26T09:47:24","modified_gmt":"2026-08-26T07:47:24","slug":"active-pharmaceutical-ingredients","status":"publish","type":"page","link":"https:\/\/arevipharma.com\/en\/services\/active-pharmaceutical-ingredients\/","title":{"rendered":"API Portfolio"},"content":{"rendered":"

API Portfolio<\/p>\n<\/div>

Our APIs meet your requirements 100%<\/h3><\/div>

Arevipharma offers a broad range of synthetic, generic active ingredients across various volume, indication and substance classes. All active ingredients are manufactured at our site in Radebeul under cGMP conditions and are already registered in many global pharmaceutical markets. In coordination with our customers, we also regularly, at short notice and reliably, undertake registration projects in countries additionally required for their marketing strategy. <\/p>\n

A key part of our active ingredient portfolio is controlled substances. Arevipharma can handle all classes of these active ingredients without any volume restrictions. This makes us one of the largest manufacturers of controlled substances in the world.<\/p>\n<\/div>

Download Portfolio PDF<\/span><\/a><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
\n
\n

APIs<\/strong><\/h3>\n
Controlled Substances<\/strong><\/h5>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Product<\/th>\nIndication<\/th>\nRegulatory Documentation<\/th>\n<\/tr>\n<\/thead>\n
Amfepramone HCl<\/td>\nAppetite depressant<\/td>\nUS-DMF, ASMF<\/td>\n<\/tr>\n
Arketamine HCl*<\/td>\nAntidepressant<\/td>\nASMF<\/td>\n<\/tr>\n
Buprenorphine<\/td>\nAnalgesic, OUD<\/td>\nCEP, US-DMF, ASMF<\/td>\n<\/tr>\n
Buprenorphine HCl<\/td>\nAnalgesic<\/td>\nCEP, US-DMF, ASMF<\/td>\n<\/tr>\n
Esketamine HCl*<\/td>\nAnalgesic, Antidepressant<\/td>\nCEP, US-DMF, ASMF<\/td>\n<\/tr>\n
Fentanyl<\/td>\nAnalgesic<\/td>\nASMF<\/td>\n<\/tr>\n
Fentanyl Citrate<\/td>\nAnalgesic<\/td>\nASMF<\/td>\n<\/tr>\n
Ketamine HCl*<\/td>\nAnalgesic<\/td>\nCEP, US-DMF, ASMF<\/td>\n<\/tr>\n
Remifentanil HCl<\/td>\nAnalgesic<\/td>\nASMF<\/td>\n<\/tr>\n
Tilidine HCl HH<\/td>\nAnalgesic<\/td>\nASMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*Not a controlled substance in several countries (e.g., Germany)<\/p>\n<\/div>\n<\/div><\/div>

\n
\n
Other APIs<\/strong><\/h5>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Product<\/th>\nIndication<\/th>\nRegulatory Documentation<\/th>\n<\/tr>\n<\/thead>\n
Amiodarone HCl<\/td>\nAntiarrhythmic<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Bisoprolol Fumarate<\/td>\nAntihypertensive, Beta blocker<\/td>\nCEP, US-DMF, J-DMF, ASMF<\/td>\n<\/tr>\n
Cafedrine HCl<\/td>\nCardiac Stimulant<\/td>\nASMF<\/td>\n<\/tr>\n
Cannabidiol<\/td>\nVarious<\/td>\nASMF<\/td>\n<\/tr>\n
Carbamazepine<\/td>\nAnticonvulsant<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Cetirizine 2HCl<\/td>\nAntihistamine<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Dimethylfumarate<\/td>\nPsoriasis, Multiple Sclerosis<\/td>\nUS-DMF, ASMF<\/td>\n<\/tr>\n
Doxapram HCl<\/td>\nAnaleptic<\/td>\nCEP, US-DMF, J-DMF<\/td>\n<\/tr>\n
Ebastine<\/td>\nAntihistamine<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Phenprocoumon<\/td>\nAnticoagulant<\/td>\nASMF<\/td>\n<\/tr>\n
Phytosterol<\/td>\nAnticoagulant<\/td>\nASMF<\/td>\n<\/tr>\n
Pyridostigmine Bromide<\/td>\nParasympathomimetic<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Rivastigmine<\/td>\nAlzheimer\u2019s disease<\/td>\nCEP submitted<\/td>\n<\/tr>\n
Sotalol HCl<\/td>\nAntiarrhythmic, Beta blocker<\/td>\nCEP, ASMF<\/td>\n<\/tr>\n
Sultiame<\/td>\nAnticonvulsant<\/td>\nASMF<\/td>\n<\/tr>\n
Theodrenaline HCl<\/td>\nCardiac Stimulant<\/td>\nASMF<\/td>\n<\/tr>\n
Torasemide<\/td>\nDiuretic<\/td>\nCEP, ASMF, J-DMF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div><\/div>
\n
\n
R&D Products<\/strong><\/h5>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Product<\/th>\nIndication<\/th>\nRegulatory Documentation<\/th>\n<\/tr>\n<\/thead>\n
Naloxone HCl DH<\/td>\nOpiod Antagonist, Alcohol dependence<\/td>\nValidation ongoing<\/td>\n<\/tr>\n
Naltrexone (HCl)<\/td>\nOpiod Antagonist, OUD<\/td>\nValidation ongoing<\/td>\n<\/tr>\n
Rivastigmine Tartrate<\/td>\nAlzheimer\u2019s disease<\/td>\nValidation ongoing<\/td>\n<\/tr>\n
Oxymorphon<\/td>\nAnalgesic, Intermediate<\/td>\nPilot scale<\/td>\n<\/tr>\n
Folinic Acid (Calcium Folinate, Leucovorin)<\/td>\nRescue Agent<\/td>\nValidation 2026<\/td>\n<\/tr>\n
Tirbanibulin<\/td>\nKeratosis<\/td>\nValidation 2026<\/td>\n<\/tr>\n
Nalbuphine HCl<\/td>\nAnalgesic, partial antagonist<\/td>\nValidation 2027<\/td>\n<\/tr>\n
Nalmefene HCl<\/td>\nOpiod Antagonist<\/td>\nValidation 2027<\/td>\n<\/tr>\n
Sufentanil<\/td>\nAnalgesic<\/td>\nLaboratory Assessment<\/td>\n<\/tr>\n
Tivozanib<\/td>\nAnticancer<\/td>\nLaboratory Assessment<\/td>\n<\/tr>\n
Vismodegib<\/td>\nAnticancer<\/td>\nLaboratory Assessment<\/td>\n<\/tr>\n
Alpelisib<\/td>\nAnticancer<\/td>\nUnder Evaluation<\/td>\n<\/tr>\n
Diroximel Fumarate<\/td>\nMultiple Sclerosis<\/td>\nUnder Evaluation<\/td>\n<\/tr>\n
Droperidol<\/td>\nAntiemetic<\/td>\nUnder Evaluation<\/td>\n<\/tr>\n
Remimazolam<\/td>\nAnalgesic<\/td>\nUnder Evaluation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div><\/div><\/div><\/div>

We look forward to your inquiry.<\/p><\/h3><\/div>

<\/i>CDMO<\/span><\/a><\/div><\/div><\/div>
<\/i>Sales<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3311,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-3296","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/pages\/3296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/comments?post=3296"}],"version-history":[{"count":5,"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/pages\/3296\/revisions"}],"predecessor-version":[{"id":3648,"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/pages\/3296\/revisions\/3648"}],"up":[{"embeddable":true,"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/pages\/3311"}],"wp:attachment":[{"href":"https:\/\/arevipharma.com\/en\/wp-json\/wp\/v2\/media?parent=3296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}